How were Sio Gene Therapies' earnings last quarter?

Sio Gene Therapies Inc. (NASDAQ:SIOX) posted its quarterly earnings results on Friday, November, 12th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.12.

When did Sio Gene Therapies' stock split?

Sio Gene Therapies's stock reverse split before market open on Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

NASDAQ:SIOX

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free SIOX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.45
▼
$0.48
50-Day Range: $0.38
▼
$0.48
52-Week Range: $0.25
▼
$0.50

Volume: 40,400 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Social Media

Get Sio Gene Therapies alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Sio Gene Therapies Stock (NASDAQ:SIOX)

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

SIOX Stock News Headlines

February 2, 2024 | finance.yahoo.com

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share

November 22, 2023 | morningstar.com

Sio Gene Therapies Inc SIOX

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

November 1, 2023 | thestreet.com

Two Promising Gene Therapy Stocks Tackling Eye Disease

July 19, 2023 | fool.com

Sio Gene Therapies (NASDAQ: AXGT)

July 13, 2023 | finance.yahoo.com

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

May 23, 2023 | nbcnews.com

A new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.

February 14, 2023 | finance.yahoo.com

Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 26, 2023 | seekingalpha.com

SIOX Sio Gene Therapies Inc.

December 14, 2022 | finance.yahoo.com

Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution

November 10, 2022 | bizjournals.com

Following layoffs, gene therapy firm leaves Durham

November 10, 2022 | finance.yahoo.com

Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results

October 31, 2022 | finance.yahoo.com

Sio Gene Therapies (NASDAQ:SIOX) Will Have To Spend Its Cash Wisely

August 11, 2022 | finance.yahoo.com

Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results

August 5, 2022 | uk.finance.yahoo.com

Sio Gene Therapies Inc. (SIOX)

June 14, 2022 | bizjournals.com

Gene therapy firm in Durham slashes headcount as biotech stumbles

June 14, 2022 | finance.yahoo.com

Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results

April 28, 2022 | markets.businessinsider.com

Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet

April 28, 2022 | finance.yahoo.com

Sio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares Plunge

April 27, 2022 | finance.yahoo.com

Sio Gene Therapies Provides Corporate Update

February 11, 2022 | finance.yahoo.com

Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results

February 2, 2022 | benzinga.com

SVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1

February 1, 2022 | benzinga.com

HC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7

February 1, 2022 | msn.com

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

January 4, 2022 | nasdaq.com

Companies Like Sio Gene Therapies (NASDAQ:SIOX) Are In A Position To Invest In Growth

November 12, 2021 | finance.yahoo.com

We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely

See More Headlines

Receive SIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/12/2021
Today: 4/19/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SIOX
CUSIP: N/A
CIK: 1636050
Web: siogtx.com
Phone: (646) 677-6770
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: No Data
Beta: 1.14

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. David W. Nassif J.D. (Age 70)
CEO, CFO, Chief Accounting Officer, General Counsel & Director
Comp: $699.52k

Key Competitors

View All Competitors

SIOX Stock Analysis - Frequently Asked Questions

How were Sio Gene Therapies' earnings last quarter?: Sio Gene Therapies Inc. (NASDAQ:SIOX) posted its quarterly earnings results on Friday, November, 12th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.12.
When did Sio Gene Therapies' stock split?: Sio Gene Therapies's stock reverse split before market open on Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

This page (NASDAQ:SIOX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

About Sio Gene Therapies Stock (NASDAQ:SIOX)

SIOX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SIOX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info